The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AZN ASTRAZENECA PLC ORD SHS $0.25




 Page 1 of 5

| 1 | 2 | 3 | 4 | 5 | Next

Time/Date Code Headline Source Impact
11:30 01-Sep-2015 AZN Total Voting Rights RNS +0.23% Up
07:04 01-Sep-2015 AZN AstraZeneca and Valeant to partner on brodalumab RNS +0.23% Up
16:00 28-Aug-2015 AZN Director/PDMR Shareholding RNS +2.26% Up
07:00 24-Aug-2015 AZN AstraZeneca appoints Dr Sean Bohen RNS -5.07% Down
15:00 03-Aug-2015 AZN Total Voting Rights RNS +3.27% Up
07:01 30-Jul-2015 AZN Half Yearly Report RNS +3.28% Up
09:00 29-Jul-2015 AZN Notice of Results RNS +1.74% Up
11:00 27-Jul-2015 AZN Confirmation of Change in ADS Ratio RNS -1.49% Down
07:00 27-Jul-2015 AZN AstraZeneca agreement with Genzyme on Caprelsa RNS -1.49% Down
11:00 17-Jul-2015 AZN Holding(s) in Company RNS -0.31% Down
07:05 17-Jul-2015 AZN AZ completes agreement with Tillotts for Entocort RNS -0.31% Down
07:00 14-Jul-2015 AZN IRESSA approved by US FDA RNS +2.25% Up
07:32 09-Jul-2015 AZN Agreement with Tillotts on Entocort RNS +3.10% Up
11:00 01-Jul-2015 AZN Total Voting Rights RNS +0.30% Up
12:00 26-Jun-2015 AZN Change in ADS ratio RNS -2.45% Down
11:30 25-Jun-2015 AZN Publication of Prospectus RNS -2.53% Down
14:00 16-Jun-2015 AZN Director/PDMR Shareholding RNS -0.98% Down
15:00 03-Jun-2015 AZN Holding(s) in Company RNS -1.74% Down
15:00 01-Jun-2015 AZN AstraZeneca PLC - Blocklisting Interim Review RNS -1.42% Down
15:00 01-Jun-2015 AZN Total Voting Rights RNS -1.42% Down

 Page 1 of 5

| 1 | 2 | 3 | 4 | 5 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 2 Kingdom Street, London, W2 6BD, United Kingdom
Company website http://www.astrazeneca....
Market cap(in millions)* £ 51,954.42
Listing/Admission to trading 01 Jun 1993
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-Sep-15
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 500
SEDOL 0989529
ISIN number GB0009895292



ASTRAZENECA share - news analysis